Abstract

Mild Cognitive Impairment (MCI) is increasingly recognized as a critical transitional stage between normal aging and more severe neurodegenerative disorders such as Alzheimer’s disease (AD). Individuals with MCI experience noticeable cognitive decline, particularly in memory, but retain functional independence. This review explores the clinical implications of MCI as a precursor to Alzheimer’s disease and the potential for early intervention. Studies suggest that early detection of MCI, through cognitive assessments and biomarkers, can identify individuals at high risk for progression to Alzheimer’s. Early intervention strategies, including pharmacological treatments, cognitive training, and lifestyle modifications, may help slow disease progression and improve quality of life. However, while evidence supports the potential for intervention, the clinical approach to managing MCI remains complex and requires further refinement. The review highlights the importance of early diagnosis, tailored interventions, and continuous monitoring of MCI patients. Ultimately, an improved understanding of MCI can enhance the prognosis of Alzheimer’s disease and other neurodegenerative conditions.